Pharmaceutical and Healthcare pipeline guide - Myocarditis - Pipeline Review, H2
The latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Pipeline Review, H2 2017, provides an overview of the Myocarditis (Cardiovascular) pipeline landscape. Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain, rapid or abnormal heartbeat, shortness of breath, at rest or during physical activity, fluid retention with swelling of legs, ankles and feet and fatigue. Treatment includes antibiotics, anti-inflammatory medicines to reduce swelling and diuretics to remove excess water from the body. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Myocarditis - Pipeline Review , H2 2017, provides comprehensive information on the therapeutics under development for Myocarditis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of adminis...